109 related articles for article (PubMed ID: 26910242)
1. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
Mori T; Koh H; Onishi Y; Kako S; Onizuka M; Kanamori H; Ozawa Y; Kato C; Iida H; Suzuki R; Ichinohe T; Kanda Y; Maeda T; Nakao S; Yamazaki H
Int J Hematol; 2016 Apr; 103(4):461-8. PubMed ID: 26910242
[TBL] [Abstract][Full Text] [Related]
2. Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?
Sabloff M; Sobecks RM; Ahn KW; Zhu X; de Lima M; Brown JR; Inamoto Y; Holland HK; Aljurf MD; Laughlin MJ; Kamble RT; Hsu JW; Wirk BM; Seftel M; Lewis ID; Arora M; Alyea EP; Kalaycio ME; Cortes J; Maziarz RT; Gale RP; Saber W
Biol Blood Marrow Transplant; 2014 Mar; 20(3):421-4. PubMed ID: 24321745
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.
Inamoto Y; Flowers ME; Wang T; Urbano-Ispizua A; Hemmer MT; Cutler CS; Couriel DR; Alousi AM; Antin JH; Gale RP; Gupta V; Hamilton BK; Kharfan-Dabaja MA; Marks DI; Ringdén OT; Socié G; Solh MM; Akpek G; Cairo MS; Chao NJ; Hayashi RJ; Nishihori T; Reshef R; Saad A; Shah A; Teshima T; Tallman MS; Wirk B; Spellman SR; Arora M; Martin PJ
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1776-82. PubMed ID: 26033280
[TBL] [Abstract][Full Text] [Related]
4. A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.
Bemer MJ; Sorror M; Sandmaier BM; O'Donnell PV; McCune JS
Cancer Chemother Pharmacol; 2013 Sep; 72(3):607-18. PubMed ID: 23907443
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation for aplastic anemia.
Storb R
Int J Hematol; 2024 Mar; 119(3):220-230. PubMed ID: 36576660
[TBL] [Abstract][Full Text] [Related]
6. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.
Luznik L; Fuchs EJ
Immunol Res; 2010 Jul; 47(1-3):65-77. PubMed ID: 20066512
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation from haploidentical offspring donors using post-transplant cyclophosphamide versus human leukocyte antigen-matched siblings in older patients with myelodysplastic syndrome.
Shimomura Y; Kitamura T; Konuma T; Nakaya Y; Doki N; Sawa M; Nakamae H; Eto T; Nishida T; Ohigashi H; Ota S; Onizuka M; Hiramoto N; Kawakita T; Kanda J; Ichinohe T; Atsuta Y; Itonaga H
Am J Hematol; 2024 Feb; 99(2):E42-E45. PubMed ID: 37966972
[No Abstract] [Full Text] [Related]
8. Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia.
Lucarelli G; Isgrò A; Sodani P; Gaziev J
Cold Spring Harb Perspect Med; 2012 May; 2(5):a011825. PubMed ID: 22553502
[TBL] [Abstract][Full Text] [Related]
9. Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia.
Nakamura Y; Zaimoku Y; Yamaguchi H; Yamazaki H; Kanaya M; Uchida N; Doki N; Sakurai M; Hiramoto N; Kako S; Onizuka M; Onodera K; Maruyama Y; Ohigashi H; Nishida T; Yoshihara S; Matsuoka KI; Eto T; Kanda Y; Fukuda T; Atsuta Y; Onishi Y
Ann Hematol; 2024 May; ():. PubMed ID: 38750374
[TBL] [Abstract][Full Text] [Related]
10. Aplastic anemia.
Young NS; Scheinberg P; Calado RT
Curr Opin Hematol; 2008 May; 15(3):162-8. PubMed ID: 18391779
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of exercise rehabilitation on aplastic anemia patients receiving hematopoietic stem cell transplantation: study protocol for a randomized controlled trial.
Ye M; Liu T; Mao X; Tan X; Wang J; Xu M
Trials; 2024 Jun; 25(1):361. PubMed ID: 38840199
[TBL] [Abstract][Full Text] [Related]
12. Non-myeloablative allogeneic HSCT in adult patients with sickle cell disease: Multiple take-home points from the Saudi Arabia experience.
Rondelli D
Am J Hematol; 2024 Jun; 99(6):1021-1022. PubMed ID: 38606977
[No Abstract] [Full Text] [Related]
13. Mismatched donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations.
Caprice T; Fan W; Kim J; Faramand R; Mishra A; Perez L; Khimani F; Lazaryan A; Ochoa-Bayona JL; Liu H; Jain MD; Nieder M; Anasetti C; Nishihori T; Pidala JA; Bejanyan N; Elmariah H
Am J Hematol; 2024 Jun; 99(6):1196-1200. PubMed ID: 38546371
[No Abstract] [Full Text] [Related]
14. The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group.
Xu ZL; Xu LP; Zhang YC; Zhou YH; Jiang EL; Zhang JP; Fu B; Ouyang GF; Song XM; Zhang XJ; Dong YJ; Li NN; Wang L; Zhang X; He PC; Kong FS; Liu HX; Liu L; Liu L; Xiao TW; Xu WW; Xu XJ; Yuan GL; Yi H; Yu D; Yu L; Huang XJ
Haematologica; 2024 Jun; 109(6):2000-2004. PubMed ID: 38299673
[No Abstract] [Full Text] [Related]
15. [Advances in nutritional support for children undergoing hematopoietic stem cell transplantation].
Zhang T; Jiang MZ
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Mar; 26(3):308-314. PubMed ID: 38557385
[TBL] [Abstract][Full Text] [Related]
16. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.
Brodsky RA; Jones RJ
Autoimmunity; 2008 Dec; 41(8):596-600. PubMed ID: 18958751
[TBL] [Abstract][Full Text] [Related]
17. A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Severely Underweight Patient with Aplastic Anemia.
Banceviča L; Žučenka A
Case Rep Hematol; 2024; 2024():2044820. PubMed ID: 38469371
[TBL] [Abstract][Full Text] [Related]
18. Reduction of intramedullary apoptosis after stem cell transplantation in black african variant of pediatric sickle cell anemia.
Isgrò A; Sodani P; Marziali M; Gaziev J; Fraboni D; Paciaroni K; Gallucci C; De Angelis G; Alfieri C; Ribersani M; Armiento D; Roveda A; Andreani M; Testi M; Lucarelli G
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014054. PubMed ID: 25045462
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide.
Ikeda DJ; DeFilipp Z; Collier K; Chen YB; Dey BR; El-Jawahri A; Frigault MJ; Leick MB; McAfee SL; Newcomb RA; O'Donnell PV; Spitzer TR
Bone Marrow Transplant; 2024 Jan; 59(1):131-133. PubMed ID: 37821533
[No Abstract] [Full Text] [Related]
20. Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a case of leukocyte adhesion deficiency type III.
Barhoom D; Behfar M; Mohseni R; Hamidieh AA
Hematol Transfus Cell Ther; 2024; 46(3):300-302. PubMed ID: 35256330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
